Dysregulation of Long Noncoding RNA NEAT1/miR-199a-5/BiP Axis in Patients with Diabetic Neuropathy

Lab Med. 2023 Mar 7;54(2):160-165. doi: 10.1093/labmed/lmac082.

Abstract

Objective: Diabetic neuropathy (DN) is a type of nerve damage and the most common complication of diabetes. Regarding the association between endoplasmic reticulum (ER) stress with the pathogenesis of neuropathy, this study aims to examine binding immunoglobulin protein (BiP) gene expression and long noncoding RNA nuclear enriched abundant transcript 1 (NEAT1), miR-199a-5 as its regulator in the peripheral blood of DN patients compared to diabetic patients without neuropathy.

Methods: Peripheral blood samples were obtained from DN (n = 20) patients and diabetic patients without neuropathy (non-DN) (n = 20). After RNA extraction from peripheral blood mononuclear cells, reverse transcription-quantitative polymerase chain reaction was performed to evaluate RNA expression.

Results: The results showed that the expression level of NEAT1 and BiP genes in the DN group increased significantly compared to the non-DN group. Also, the expression level of miR-199a-5p in the DN group was significantly downregulated.

Conclusion: As a result, the axis of NEAT1, miR-199a-5p, and BiP may have a role in the DN pathogenesis.

Keywords: miR-199a-5; BiP; NEAT1; diabetic neuropathy; endoplasmic reticulum stress.

MeSH terms

  • Diabetes Mellitus*
  • Diabetic Neuropathies* / genetics
  • Humans
  • Leukocytes, Mononuclear / metabolism
  • MicroRNAs* / genetics
  • MicroRNAs* / metabolism
  • RNA, Long Noncoding* / genetics
  • RNA, Long Noncoding* / metabolism

Substances

  • MicroRNAs
  • RNA, Long Noncoding